CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: bendroflumethiazide
Accession: CHEBI:3013
browse the term
Definition: A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Synonyms: related_synonym: +--3-benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide; 6-trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide; Formula=C15H14F3N3O4S2; InChI=1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23); InChIKey=HDWIHXWEUNVBIY-UHFFFAOYSA-N; SMILES=NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F; bendrofluazide; bendroflumethiazidum; bendroflumetiazida; benzhydroflumethiazide
alt_id: CHEBI:615239
xref: CAS:73-48-3; DrugBank:DB00436; Drug_Central:305; KEGG:C07758; KEGG:D00650; LINCS:LSM-1816
xref_mesh: MESH:D001539
xref: PMID:19056282; Patent:GB863474; Patent:US3392168; Reaxys:373316; Wikipedia:Bendroflumethiazide
G
Apob
apolipoprotein B
affects expression
ISO
Bendroflumethiazide affects the expression of APOB protein
CTD
PMID:2344503
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Ren
renin
increases expression
ISO
Bendroflumethiazide results in increased expression of REN protein
CTD
PMID:62162
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Slc12a3
solute carrier family 12 member 3
increases response to substance
EXP
SLC12A3 protein results in increased susceptibility to Bendroflumethiazide
CTD
PMID:18480177
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
G
Slc22a6
solute carrier family 22 member 6
decreases activity increases secretion
ISO
Bendroflumethiazide results in decreased activity of SLC22A6 protein SLC22A6 protein results in increased secretion of Bendroflumethiazide
CTD
PMID:18216144
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
decreases activity increases secretion
ISO
Bendroflumethiazide results in decreased activity of SLC22A8 protein SLC22A8 protein results in increased secretion of Bendroflumethiazide
CTD
PMID:18216144
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Tpmt
thiopurine S-methyltransferase
decreases activity
ISO
Bendroflumethiazide results in decreased activity of TPMT protein
CTD
PMID:8866635
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
G
Vegfc
vascular endothelial growth factor C
decreases expression
EXP
Bendroflumethiazide results in decreased expression of VEGFC protein
CTD
PMID:20625077
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all